vimarsana.com

Page 172 - Dexcom Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Axonics (NASDAQ:AXNX) versus DexCom (NASDAQ:DXCM) Critical Comparison

Axonics (NASDAQ:AXNX – Get Rating) and DexCom (NASDAQ:DXCM – Get Rating) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership and valuation. Analyst Recommendations This is a summary of recent ratings for Axonics and […]

Wearable Healthcare Devices Market is likely to register CAGR of 13% through 2032

The global wearable healthcare devices market size was valued at US$ 16 billion in 2021 and is predicted to reach US$ 30 billion by 2026. Furthermore, the entire demand for wearable healthcare devices is expected to grow at a 13% CAGR between 2022 and 2032, reaching roughly US$ 61 Billion by the end of 2032.Accordin.

Simplicity Solutions LLC Buys 1,029 Shares of DexCom, Inc (NASDAQ:DXCM)

Simplicity Solutions LLC increased its position in DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 25.7% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 5,033 shares of the medical device company’s stock after acquiring an additional 1,029 shares during the quarter. Simplicity Solutions LLC’s holdings in DexCom were worth $570,000 at the end of […]

BTIG Research Raises DexCom (NASDAQ:DXCM) Price Target to $132 00

DexCom (NASDAQ:DXCM – Get Rating) had its price objective lifted by BTIG Research from $126.00 to $132.00 in a research report released on Monday morning, The Fly reports. They currently have a buy rating on the medical device company’s stock. Several other research firms also recently weighed in on DXCM. Stifel Nicolaus increased their price […]

Profund Advisors LLC Sells 1,476 Shares of DexCom, Inc (NASDAQ:DXCM)

Profund Advisors LLC reduced its position in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 6.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,883 shares of the medical device company’s stock after selling 1,476 shares […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.